Literature DB >> 2786557

Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach.

W C Mathews1, E Ferdon, C Bennett, D Kanouse.   

Abstract

Mortality during hospital care of AIDS-associated Pneumocystis carinii pneumonia (PCP) varies as much as 3-fold among reporting institutions. Prognostic factors for death during an episode of PCP have been identified that may be useful risk adjustors for quality-of-care studies. We illustrate a risk adjustment approach to evaluating institutional performance for PCP using a pilot data set from two Southern California hospitals differing widely in crude PCP death rates (61 vs 27%). Using admission AaDO2, hemoglobin and age in a logistic prediction model for hospital death, we found that outcomes in 90% of cases could be accurately classified. Nearly all of the "excess" mortality of the poor outcome hospital could be explained by greater pulmonary severity on admission. We discuss four conceptual issues in design of AIDS quality-of-care studies: confounding by therapeutic intention, defining relevant treatment components, determining the range of co-morbidity, and truncation of the episode of care.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786557     DOI: 10.1016/0895-4356(89)90131-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.

Authors:  R F Miller; E Allen; A Copas; M Singer; S G Edwards
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

2.  Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia.

Authors:  T Bauer; S Ewig; E Hasper; J K Rockstroh; B Lüderitz
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

Review 3.  Definition of a core set of quality indicators for the assessment of HIV/AIDS clinical care: a systematic review.

Authors:  Emanuel Catumbela; Victor Certal; Alberto Freitas; Carlos Costa; António Sarmento; Altamiro da Costa Pereira
Journal:  BMC Health Serv Res       Date:  2013-06-28       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.